Thus, down‐regulation of E‐cadherin is associated with poor prognosis in numerous malignancies including prostate cancer (Corso et al., 2013; Richmond et al., 1997; Siu et al., 2013). The gene discussed is CDH1; the disease is prostate carcinoma.